Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Occurrence of elder abuse · Carers of elderly persons with a responsibility for detecting abuse Interventions for preventing abuse in the elderly (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adherence · adults with hearing loss who use hearing aids Interventions to improve hearing aid use in adult auditory rehabilitation (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Quality of life · adults with hearing loss who use hearing aids Interventions to improve hearing aid use in adult auditory rehabilitation (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse effects · adults with hearing loss who use hearing aids Interventions to improve hearing aid use in adult auditory rehabilitation (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Daily hours of hearing aid use · adults with hearing loss who use hearing aids Interventions to improve hearing aid use in adult auditory rehabilitation (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse effects · adults with hearing loss who use hearing aids Interventions to improve hearing aid use in adult auditory rehabilitation (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Hearing aid benefit · adults with hearing loss who use hearing aids Interventions to improve hearing aid use in adult auditory rehabilitation (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Time to first passage of stool (hours, MD, 95% CI) · adults having abdominal surgery Perioperative dexmedetomidine for acute pain after abdominal surgery in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Hypofractionated radiotherapy vs conventional radiotherapy Event‐free survival · children and young adults with diffuse brainstem glioma Radiotherapy for diffuse brainstem glioma in children and young adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Hypofractionated radiotherapy vs conventional radiotherapy Quality of life · children and young adults with diffuse brainstem glioma Radiotherapy for diffuse brainstem glioma in children and young adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Hypofractionated radiotherapy vs conventional radiotherapy Neurological response · children and young adults with diffuse brainstem glioma Radiotherapy for diffuse brainstem glioma in children and young adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Hypofractionated radiotherapy vs conventional radiotherapy Radiological response · children and young adults with diffuse brainstem glioma Radiotherapy for diffuse brainstem glioma in children and young adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Hyperfractionated radiotherapy vs conventional radiotherapy Progression‐free survival · children and young adults with diffuse brainstem glioma Radiotherapy for diffuse brainstem glioma in children and young adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Hyperfractionated radiotherapy vs conventional radiotherapy Quality of life · children and young adults with diffuse brainstem glioma Radiotherapy for diffuse brainstem glioma in children and young adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Hyperfractionated radiotherapy vs conventional radiotherapy Neurological response · children and young adults with diffuse brainstem glioma Radiotherapy for diffuse brainstem glioma in children and young adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Pyridoxine vs placebo Severity, reduction or cessation in nausea/vomiting 2. Quality of life outcomes 3. Pregnancy complications 4. Adverse fetal/neonatal outcomes · pregnant women with hyperemesis gravidarum Interventions for treating hyperemesis gravidarum (2016) · Cochrane | no estimate extracted | NR | No studies |
Metoclopramide vs ondansetron Severity, reduction or cessation in nausea/vomiting 2.Days of hospital admission 3. Pregnancy complications 4. Adverse fetal/neonatal outcomes · pregnant women with hyperemesis gravidarum Interventions for treating hyperemesis gravidarum (2016) · Cochrane | no estimate extracted | NR | No studies |
Metoclopramide vs promethazine Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Days of hospital admission 4. Pregnancy complications 5. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum Interventions for treating hyperemesis gravidarum (2016) · Cochrane | no estimate extracted | NR | No studies |
Ondansetron vs promethazine Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Quality of life outcomes 4. Pregnancy complications 5. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum Interventions for treating hyperemesis gravidarum (2016) · Cochrane | no estimate extracted | NR | No studies |
Corticosteroids vs promethazine Days of hospital admission 2. Quality of life outcomes 3. Pregnancy complications · Pregnant women with hyperemesis gravidarum Interventions for treating hyperemesis gravidarum (2016) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs placebo Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Days of hospital admission 4. Intervention side effects · pregnant women with hyperemesis gravidarum Interventions for treating hyperemesis gravidarum (2016) · Cochrane | no estimate extracted | NR | No studies |
Corticosteroids vs placebo Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Quality of life outcomes · Pregnant women with hyperemesis gravidarum Interventions for treating hyperemesis gravidarum (2016) · Cochrane | no estimate extracted | NR | No studies |
Acupuncture vs metoclopramide Number of episodes of emesis 2. Days of hospital admission 3. Intervention side effects 4. Quality of life outcomes 5. Pregnancy complications 6. Adverse fetal/neonatal outcomes · pregnant women with hyperemesis gravidarum Interventions for treating hyperemesis gravidarum (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR There was no evidence of differences in the number of serious adverse events for any of the comparisons Quality of evidence = very low1,2,3. · people undergoing liver resection Methods to decrease blood loss during liver resection: a network meta‐analysis (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR None of the trials reported this outcome at any time point. · people undergoing liver resection Methods to decrease blood loss during liver resection: a network meta‐analysis (2016) · Cochrane | no estimate extracted | NR | No studies |
Sulodexide + local treatment vs local treatment Direct costs · patients with venous leg ulcers Sulodexide for treating venous leg ulcers (2016) · Cochrane | no estimate extracted | NR | No studies |
Sulodexide + local treatment vs local treatment Time to complete ulcer healing · patients with venous leg ulcers Sulodexide for treating venous leg ulcers (2016) · Cochrane | no estimate extracted | NR | No studies |
Sulodexide + local treatment vs local treatment Change in absolute ulcer size · patients with venous leg ulcers Sulodexide for treating venous leg ulcers (2016) · Cochrane | no estimate extracted | NR | No studies |
Sulodexide + local treatment vs local treatment Ulcer recurrence · patients with venous leg ulcers Sulodexide for treating venous leg ulcers (2016) · Cochrane | no estimate extracted | NR | No studies |
Sulodexide + local treatment vs local treatment Health‐related quality of life · patients with venous leg ulcers Sulodexide for treating venous leg ulcers (2016) · Cochrane | no estimate extracted | NR | No studies |
Betahistine vs placebo Benefits · patients with symptoms of vertigo Betahistine for symptoms of vertigo (2016) · Cochrane | no estimate extracted | NR | No studies |
Betahistine vs placebo Harms · patients with symptoms of vertigo Betahistine for symptoms of vertigo (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Test result GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Test result GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Test result GenoType® MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Pain · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Reoperation rate1 · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Pain · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life1 · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Global assessment of treatment success1 · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Hip dislocation1 · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Reoperation rate1 · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Total adverse events1 · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Global assessment of treatment success · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Reoperation rate · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Pain · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Function · people following primary uncemented THA Assistive devices, hip precautions, environmental modifications and training to prevent dislocation and… (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs RISPERIDONE Clinically important change in life skills (long term) ‐ not reported · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs RISPERIDONE Quality of life (long term) ‐ not reported · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |